Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

IN Ketodex (D2K4)

Small molecule

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Timeline

Expected Milestones

Q4 2026

Phase 2/3Recruiting

Sedation

NCT04195256

Clinical

Trials by Indication[1]

Sedation1 trial

Intranasal Dexmedetomidine Plus Ketamine for Procedural Sedation

Recruiting·NNaveen Poonai·Phase 2/3·NCT04195256·400 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for IN Ketodex (D2K4). U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — IN Ketodex (D2K4) compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for IN Ketodex (D2K4). EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Naveen Poonai company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Company: NNaveen Poonai

Related News